(Q44247685)

1 December 2017

Human monoclonal antibodies to HIV-1: cross-reactions with gag and env products (English)

1 reference

1 December 2017

Pollock BJ

1

1 reference

1 December 2017

McKenzie AS

2

1 reference

1 December 2017

Kemp BE

3

1 reference

1 December 2017

McPhee DA

4

1 reference

1 December 2017

D'Apice AJ

5

1 reference

1 December 2017

1 December 1989

1 reference

Clinical and Experimental Immunology

1 December 2017

1 reference

1 December 2017

78

1 reference

1 December 2017

3

1 reference

1 December 2017

323-328

1 reference

Characterization of serum neutralization response to the human immunodeficiency virus (HIV).

1 December 2017

1 reference

12 December 2020

Human immunodeficiency virus type 1-neutralizing monoclonal antibodies which react with p17 core protein: characterization and epitope mapping

1 reference

12 December 2020

Long-term evaluation of HIV antigen and antibodies to p24 and gp41 in patients with hemophilia. Potential clinical importance

1 reference

12 December 2020

Characterization and epitope mapping of a human monoclonal antibody reactive with the envelope glycoprotein of human immunodeficiency virus.

1 reference

12 December 2020

Monitoring of solid phase peptide synthesis by an automated spectrophotometric picrate method

1 reference

12 December 2020

A rapid single step staining technique for DNA analysis by flow microfluorimetry

1 reference

12 December 2020

Quantitative monitoring of solid-phase peptide synthesis by the ninhydrin reaction.

1 reference

12 December 2020

Type C virus particles in a cord T-cell line derived by co-cultivating normal human cord leukocytes and human leukaemic T cells

1 reference

12 December 2020

ELISA assay for quantitative measurement of human immunoglobulins IgA, IgG, and IgM in nanograms

1 reference

12 December 2020

UC 729-6, a human lymphoblastoid B-cell line useful for generating antibody-secreting human-human hybridomas

1 reference

12 December 2020

Antibodies Reactive with Human T-Lymphotropic Retroviruses (HTLV-III) in the Serum of Patients with AIDS

1 reference

12 December 2020

Detection of IgG antibodies to lymphadenopathy-associated virus in patients with AIDS or lymphadenopathy syndrome

1 reference

12 December 2020

Seroepidemiological studies of human T-lymphotropic retrovirus type III in acquired immunodeficiency syndrome.

1 reference

12 December 2020

Antibodies to HTLV-III in Swiss patients with AIDS and pre-AIDS and in groups at risk for AIDS.

1 reference

12 December 2020

Nucleotide sequence of the AIDS virus, LAV

1 reference

12 December 2020

Studies of in vitro activation and differentiation of human B lymphocytes. I. Phenotypic and functional characterization of the B cell population responding to anti-Ig antibody

1 reference

12 December 2020

Antibody to lymphadenopathy-associated virus in AIDS.

1 reference

12 December 2020

Neutralization of human T-lymphotropic virus type III by sera of AIDS and AIDS-risk patients

1 reference

12 December 2020

Variation in human T lymphotropic virus III (HTLV-III) antibodies in homosexual men: decline before onset of illness related to acquired immune deficiency syndrome (AIDS).

1 reference

12 December 2020

Distinct IgG recognition patterns during progression of subclinical and clinical infection with lymphadenopathy associated virus/human T lymphotropic virus

1 reference

12 December 2020

Virus-neutralizing activity, serologic heterogeneity, and retrovirus isolation from homosexual men in the Los Angeles area

1 reference

12 December 2020

Differential antibody responses of individuals infected with AIDS-associated retroviruses surveyed using the viral core antigen p25gag expressed in bacteria

1 reference

12 December 2020

Human T-cell lymphotropic virus type III (HTLV-III) core antigens: synthesis in Escherichia coli and immunoreactivity with human sera

1 reference

12 December 2020

Prospect for prevention of human immunodeficiency virus infection: purified 120-kDa envelope glycoprotein induces neutralizing antibody

1 reference

12 December 2020

Induction of anti-HIV neutralizing antibodies by synthetic peptides

1 reference

12 December 2020

Human immunodeficiency virus neutralizing antibodies recognize several conserved domains on the envelope glycoproteins

1 reference

12 December 2020

Antibody response to human immunodeficiency virus in homosexual men. Relation of antibody specificity, titer, and isotype to clinical status, severity of immunodeficiency, and disease progression

1 reference

12 December 2020

Human monoclonal antibody directed against gag gene products of the human immunodeficiency virus

1 reference

12 December 2020

The high efficiency, human B cell immortalizing heteromyeloma CB-F7. Production of human monoclonal antibodies to human immunodeficiency virus

1 reference

12 December 2020

Identification of homologous regions in human immunodeficiency virus I gp41 and human MHC class II beta 1 domain. I. Monoclonal antibodies against the gp41-derived peptide and patients' sera react with native HLA class II antigens, suggesting a role

1 reference

12 December 2020

Isolation of HIV from Australian patients with AIDS, AIDS related conditions and healthy antibody positive individuals

1 reference

12 December 2020

Monoclonal antibodies to HIV in a non-infected, immunised volunteer

1 reference

12 December 2020

Recognition of envelope and tat protein synthetic peptide analogs by HIV positive sera or plasma

1 reference

12 December 2020

Neutralizing antibodies in HIV (HTLV-III) infection: correlation with clinical outcome and antibody response against different viral proteins.

1 reference

12 December 2020

Identifiers

1 reference